Ticker
CLDXCompany Name
CELLDEX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 692.41M | $ 27.19M | 3.93% |
3/31/2025 | $ 739.47M | $ 27.19M | 3.68% |
12/31/2024 | $ 792.34M | $ 27.19M | 3.43% |
9/30/2024 | $ 823.18M | $ 27.19M | 3.3% |
6/30/2024 | $ 845.59M | $ 27.19M | 3.22% |
3/31/2024 | $ 868.85M | $ 27.19M | 3.13% |
12/31/2023 | $ 465.63M | $ 27.19M | 5.84% |
9/30/2023 | $ 280.26M | $ 27.19M | 9.7% |
6/30/2023 | $ 299.31M | $ 27.19M | 9.08% |
3/31/2023 | $ 324.52M | $ 27.19M | 8.38% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for CELLDEX THERAPEUTICS INC is calculated as follows: Intangibles [ $ 45.19M ] / Assets [ $ 255.77M ]
(=) Intang. to Assets [ 17.67% ]
Minimum
Mar 31, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.23K |
---|---|
min | 0% |
max | 23.1% |
average | 3.98% |
median | 0.51% |
std | 6.08% |